Mar 19, 2019 / 04:30PM GMT
Katie An - ROTH Capital Partners - Analyst
Hi, everyone. So we will get started. My name is Katie; I am the associate for Yasmeen Rahimi, who is the managing director, senior research analyst in biotech here at ROTH.
It is my pleasure to introduce to you the next speaker today: Sabrina Johnson of Daré Bioscience.
Sabrina Johnson - DaréBioscience - Inc. - President and CEO
Hi, thank you to all of you. It is always a pleasure to get to present and share the Daré story, so thanks for taking the time. I'm super excited to be here. So I will start by saying the presentation will contain some forward-looking statements, so please do look at our SEC filings for a full disclosure of our risks and factors.
As many of you know, we are focused on women's health. And specifically, our vision is to really become that coordinating presence, that leader in the space of women's health in terms of really assembling an interesting portfolio of products that all have an opportunity to address some of the most persistent unmet needs
Dare Bioscience Inc at ROTH Conference Transcript
Mar 19, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers